Product
Descartes-11
1 clinical trial
1 indication
Indication
Multiple MyelomaClinical trial
Phase I Safety Study of Descartes-11 in Patients With Relapsed/Refractory Multiple MyelomaStatus: Active (not recruiting), Estimated PCD: 2024-02-06
1 clinical trial
1 indication